MapLight (MPLT) CEO reports 204,146-share tax withholding and trust holdings

Rhea-AI Filing Summary

MapLight Therapeutics CEO Christopher A. Kroeger reported a tax-related share withholding tied to equity compensation. On January 27, 2026, 204,146 shares of MapLight voting common stock were withheld by the company at a price of $17.98 per share to satisfy tax obligations from restricted stock unit settlements.

Following this transaction, Kroeger held 1,626,606 shares of voting common stock directly. In addition, 101,190 shares were held indirectly through the C&M Kroeger Nominee Trust, where he and his spouse serve as co-trustees with voting and dispositive power. The retained securities remain subject to a lock-up agreement lasting 180 days after the October 26, 2025 final IPO prospectus, limiting sales or transfers except for certain permitted exceptions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kroeger Christopher A.

(Last) (First) (Middle)

C/O MAPLIGHT THERAPEUTICS, INC.

800 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CA 94063

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MapLight Therapeutics, Inc. [ MPLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Voting Common Stock	01/27/2026		F		204,146(1)	D	$17.98	1,626,606	D
Voting Common Stock								101,190	I	See footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock unit awards. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025.

2. The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.

	/s/ Kristopher L. Hanson, Attorney-in-Fact	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MapLight Therapeutics (MPLT) CEO Christopher Kroeger report on this Form 4?

Christopher Kroeger reported shares of voting common stock being withheld to cover tax obligations from restricted stock unit settlements. This is a compensation-related, non-open-market transaction rather than a discretionary sale into the market.

How many MapLight Therapeutics (MPLT) shares were withheld for taxes?

The filing shows 204,146 shares of MapLight voting common stock were withheld on January 27, 2026. The price listed for this tax withholding transaction was $17.98 per share, reflecting settlement of restricted stock unit awards.

How many MapLight (MPLT) shares does CEO Christopher Kroeger hold after the reported transaction?

After the transaction, Christopher Kroeger held 1,626,606 shares of voting common stock directly. He also had 101,190 shares held indirectly through the C&M Kroeger Nominee Trust, where he and his spouse have voting and dispositive power.

What is the C&M Kroeger Nominee Trust’s role in MapLight (MPLT) share ownership?

The C&M Kroeger Nominee Trust holds 101,190 MapLight shares reported as indirect ownership. Christopher Kroeger and his spouse serve as co-trustees of the trust and have both voting and dispositive power over these shares.

Are MapLight (MPLT) CEO Christopher Kroeger’s shares subject to an IPO lock-up?

Yes. The filing states his retained MapLight securities are subject to a 180-day lock-up following the final IPO prospectus dated October 26, 2025, restricting sales or transfers except for specified exceptions in the agreement.

Was this MapLight (MPLT) Form 4 transaction an open-market sale by the CEO?

No. The filing explains the 204,146 shares represent stock withheld by the issuer to satisfy tax withholding obligations for restricted stock unit settlements, not an open-market sale initiated by Christopher Kroeger.